☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
LA
Incyte's Pemazyre (pemigatinib) Receives the US FDA's Approval as the Novel Treatment for Adults with Previously Treated- Unresect...
April 17, 2020
Merck's Keytruda (pembrolizumab) Receives FDA's Approval for LA or Metastatic Merkel cell carcinoma (MCC)
December 20, 2018
Pfizer and Zenith Epigenetics Collaborates to Evaluate ZEN-3694 & Talazoparib for TNBC
November 22, 2018
Pfizer's Talzenna (talazoparib) Receives FDA Approval for BRCA-Mutated- HER2-Negative LA or MBC
October 11, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.
